Taiwan's pharmaceutical market has maintained steady growth in recent years. According to data from IQVIA, the sales revenue from Taiwan's drug market was NT$ 196.76 billion in 2018, up by 13.4% from 2017. Based on the increasing aged population and the rising need for medication to treat cancer and chronic diseases, the domestic market for pharmaceuticals is projected to have sustained growth.
1. Definition and Scope
2. 2018 Pharmaceutical Industry Status
3. Major Market Observations
4. Forecasts of the Global Pharmaceutical Industry
5. Potential Direction for the Development of Taiwan's Pharmaceutical Industry and Suggestions
Figure 1 2018 and 2023 Global Pharmaceutical Market Forecasts based on Economic Growth
Table 1 Subindustries and Main Products in Taiwan’s Pharmaceutical Industry